Authors:
Misaki, Y
Ezaki, I
Ariga, T
Kawamura, N
Sakiyama, Y
Yamamoto, K
Citation: Y. Misaki et al., Gene-transferred oligoclonal T cells predominantly persist in peripheral blood from an adenosine deaminase-deficient patient during gene therapy, MOL THER, 3(1), 2001, pp. 24-27
Authors:
Narita, M
Tanaka, H
Yamada, S
Abe, S
Ariga, T
Sakiyama, Y
Citation: M. Narita et al., Significant role of interleukin-8 in pathogenesis of pulmonary disease dueto Mycoplasma pneumoniae infection, CL DIAG LAB, 8(5), 2001, pp. 1028-1030
Authors:
Suzuki, M
Hatano, K
Sakiyama, Y
Kawasumi, Y
Kato, T
Ito, K
Citation: M. Suzuki et al., Age-related changes of dopamine D-1-like and D-2-like receptor binding in the F344/N rat striatum revealed by positron emission tomography and in vitro receptor autoradiography, SYNAPSE, 41(4), 2001, pp. 285-293
Authors:
Ariga, T
Kondoh, T
Yamaguchi, K
Yamada, M
Sasaki, S
Nelson, DL
Ikeda, H
Kobayashi, K
Moriuchi, H
Sakiyama, Y
Citation: T. Ariga et al., Spontaneous in vivo reversion of an inherited mutation in the Wiskott-Aldrich syndrome, J IMMUNOL, 166(8), 2001, pp. 5245-5249
Authors:
Ariga, T
Oda, N
Sanstisteban, I
Arrendondo-Vega, FX
Shioda, M
Ueno, H
Terada, K
Kobayashi, K
Hershfield, MS
Sakiyama, Y
Citation: T. Ariga et al., Molecular basis for paradoxical carriers of adenosine deaminase (ADA) deficiency that show extremely low levels of ADA activity in peripheral blood cells without immunodeficiency, J IMMUNOL, 166(3), 2001, pp. 1698-1702
Authors:
Kasahara, Y
Yachie, A
Takei, K
Kanegane, C
Okada, K
Ohta, K
Seki, H
Igarashi, N
Maruhashi, K
Katayama, K
Katoh, E
Terao, G
Sakiyama, Y
Koizumi, S
Citation: Y. Kasahara et al., Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection, BLOOD, 98(6), 2001, pp. 1882-1888
Authors:
Ariga, T
Oda, N
Yamaguchi, K
Kawamura, N
Kikuta, H
Taniuchi, S
Kobayashi, Y
Terada, K
Ikeda, H
Hershfield, MS
Kobayashi, K
Sakiyama, Y
Citation: T. Ariga et al., T-cell lines from 2 patients with adenosine deaminase (ADA) deficiency showed the restoration of ADA activity resulted from the reversion of an inherited mutation, BLOOD, 97(9), 2001, pp. 2896-2899
Authors:
Kumaki, S
Ishii, N
Minegishi, M
Ohashi, Y
Hakozaki, I
Nonoyama, S
Imai, K
Morio, T
Tsuge, I
Sakiyama, Y
Miyanoshita, A
Miura, J
Mayumi, M
Heike, T
Katamura, K
Takada, H
Izumi, I
Kamizono, J
Hibi, S
Sasaki, H
Kimura, M
Kikuta, A
Date, Y
Sako, M
Tanaka, H
Sano, K
Sugamura, K
Tsuchiya, S
Citation: S. Kumaki et al., Characterization of the gamma c chain among 27 unrelated Japanese patientswith X-linked severe combined immunodeficiency (X-SCID), HUM GENET, 107(4), 2000, pp. 406-408
Authors:
Kawamura, N
Okamura, A
Furuta, H
Katow, S
Yamada, M
Kobayashi, I
Okano, M
Kobayashi, K
Sakiyama, Y
Citation: N. Kawamura et al., Improved dysgammaglobulinaemia in congenital rubella syndrome after immunoglobulin therapy: correlation with CD154 expression, EUR J PED, 159(10), 2000, pp. 764-766
Authors:
Uyehara, T
Sato, Y
Ishizuka, H
Sakiyama, Y
Ueno, M
Sato, T
Citation: T. Uyehara et al., The first total synthesis of (+/-)-junicedranol based on a novel anionic [1,3] rearrangement, TETRAHEDR L, 41(12), 2000, pp. 1939-1942
Authors:
Yamada, M
Ariga, T
Kawamura, N
Yamaguchi, K
Ohtsu, M
Nelson, DL
Kondoh, T
Kobayashi, I
Okano, M
Kobayashi, K
Sakiyama, Y
Citation: M. Yamada et al., Determination of carrier status for the Wiskott-Aldrich syndrome by flow cytometric analysis of Wiskott-Aldrich syndrome protein expression in peripheral blood mononuclear cells, J IMMUNOL, 165(2), 2000, pp. 1119-1122
Authors:
Yamada, M
Ariga, T
Kawamura, N
Ohtsu, M
Imajoh-Ohmi, S
Ohshika, E
Tatsuzawa, O
Kobayashi, K
Sakiyama, Y
Citation: M. Yamada et al., Genetic studies of three Japanese patients with p22-phox-deficient chronicgranulomatous disease: detection of a possible common mutant CYBA allele in Japan and a genotype-phenotype correlation in these patients, BR J HAEM, 108(3), 2000, pp. 511-517
Authors:
Oda, A
Ikeda, Y
Ochs, HD
Druker, BJ
Ozaki, K
Handa, M
Ariga, T
Sakiyama, Y
Witte, ON
Wahl, MI
Citation: A. Oda et al., Rapid tyrosine phosphorylation and activation of Bruton's tyrosine/Tec kinases in platelets induced by collagen binding or CD32 cross-linking, BLOOD, 95(5), 2000, pp. 1663-1670
Authors:
Okano, M
Yamada, M
Ohtsu, M
Kawamura, N
Sakiyama, Y
Aoi, K
Gandoh, S
Fujita, M
Kobayashi, K
Citation: M. Okano et al., Successful treatment with methylprednisolone pulse therapy for a life-threatening pulmonary insufficiency in a patient with chronic granulomatous disease following pulmonary invasive Aspergillosis and Burkholderia cepacia infection, RESPIRATION, 66(6), 1999, pp. 551-554
Authors:
Kawamura, N
Ariga, T
Ohtsu, M
Kobayashi, I
Yamada, M
Tame, A
Furuta, H
Okano, M
Egashira, M
Niikawa, N
Kobayashi, K
Sakiyama, Y
Citation: N. Kawamura et al., In vivo kinetics of transduced cells in peripheral T cell-directed gene therapy: Role of CD8(+) cells in improved immunological function in an adenosine deaminase (ADA)-SCID patient, J IMMUNOL, 163(4), 1999, pp. 2256-2261
Authors:
Ariga, T
Yamada, M
Wada, T
Saitoh, S
Sakiyama, Y
Citation: T. Ariga et al., Detection of lymphocytes and granulocytes expressing the mutant WASP message in carriers of Wiskott-Aldrich syndrome, BR J HAEM, 104(4), 1999, pp. 893-900
Authors:
Yamada, M
Ohtsu, M
Kobayashi, I
Kawamura, N
Kobayashi, K
Ariga, T
Sakiyama, Y
Nelson, DL
Tsuruta, S
Anakura, M
Ishikawa, N
Citation: M. Yamada et al., Flow cytometric analysis of Wiskott-Aldrich syndrome (WAS) protein in lymphocytes from WAS patients and their familial carriers, BLOOD, 93(2), 1999, pp. 756-757
Authors:
Onodera, M
Nelson, DM
Sakiyama, Y
Candotti, F
Blaese, RM
Citation: M. Onodera et al., Gene therapy for severe combined immunodeficiency caused by adenosine deaminase deficiency: Improved retroviral vectors for clinical trials, ACT HAEMAT, 101(2), 1999, pp. 89-96
Authors:
Kawamura, N
Ariga, T
Ohtsu, M
Yamada, M
Tame, A
Furuta, H
Kobayashi, I
Okano, M
Yanagihara, Y
Sakiyama, Y
Citation: N. Kawamura et al., Elevation of serum IgE level and peripheral eosinophil count during T lymphocyte-directed gene therapy for ADA deficiency: implication of Tc2-like cells after gene transduction procedure, IMMUNOL LET, 64(1), 1998, pp. 49-53